<doc>
  <docmeta id="113hr3392ih">
    <bill congress="113" type="hr" number="3392" version="ih"/>
    <revision size="12177" annotations="0" status="complete" id="3" commit-time="2013-11-07T21:56:36Z" committer="mbohmer" doc="113hr3392ih/3.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HAC0B7299DD2F467480E2F26E6965C82E" public-private="public">
  <metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 3392 IH: Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-10-30</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
    <congress>113th CONGRESS</congress>
    <session>1st Session</session>
    <legis-num>H. R. 3392</legis-num>
    <current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
    <action>
      <action-date date="20131030">October 30, 2013</action-date>
      <action-desc>
        <sponsor name-id="B001257">Mr. Bilirakis</sponsor> (for himself and <cosponsor name-id="L000570">Mr. Ben Ray Luján of New Mexico</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
    </action>
    <legis-type>A BILL</legis-type>
    <official-title>To amend title XVIII of the Social Security Act to provide for a PDP safety program to prevent fraud and abuse in the dispensing of controlled substances under part D of the Medicare program, and for other purposes.</official-title>
  </form>
  <legis-body id="HA0E236D12B9E4C8C9B6BDBAA6D141CD7" style="OLC">
    <section id="H2F16AC99FD20447F9981DE342CF5A3D4" section-type="section-one">
      <enum>1.</enum>
      <header>Short title; table of contents</header>
      <subsection id="H5485329A041C45808AFFD6FFBBDE20CC">
        <enum>(a)</enum>
        <header>Short title</header>
        <text display-inline="yes-display-inline">This Act may be cited as the <quote>
            <short-title>Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013</short-title>
          </quote>.</text>
      </subsection>
      <subsection id="H1B3FDC7C8878463FBD26E8892CCEF79E">
        <enum>(b)</enum>
        <header>Table of contents</header>
        <text>The table of contents of this Act is as follows:</text>
        <toc container-level="legis-body-container" lowest-bolded-level="division-lowest-bolded" lowest-level="section" quoted-block="yes-quoted-block" regeneration="yes-regeneration">
          <toc-entry idref="H2F16AC99FD20447F9981DE342CF5A3D4" level="section">Sec. 1. Short title; table of contents.</toc-entry>
          <toc-entry idref="HC6BC3D676A1A46F0BBAFC6D18EFF77D7" level="section">Sec. 2. Establishing PDP safety program to prevent fraud and abuse in Medicare prescription drug plans.</toc-entry>
          <toc-entry idref="H1F6FE22FF3F142649500E5F76587464D" level="section">Sec. 3. Part D suspension of claims payment.</toc-entry>
          <toc-entry idref="HB5D8B2729502477EA12FE86C39892B90" level="section">Sec. 4. Improving activities of Medicare Drug Integrity Contractors (MEDICs).</toc-entry>
          <toc-entry idref="H76262ABCFAA84AA2BF32B3311D838DAC" level="section">Sec. 5. Requiring e-prescribing for coverage of covered part D controlled substances.</toc-entry>
        </toc>
      </subsection>
    </section>
    <section id="HC6BC3D676A1A46F0BBAFC6D18EFF77D7">
      <enum>2.</enum>
      <header>Establishing PDP safety program to prevent fraud and abuse in Medicare prescription drug plans</header>
      <subsection id="H94EECC5BBAD948C39E681617D4A86017">
        <enum>(a)</enum>
        <header>PDP safety program</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1860D–4/ss:c">Section 1860D–4(c) of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-104">
              <cato:entity-ref entity-type="uscode" value="usc/42/1395w–104/c">42 U.S.C. 1395w–104(c)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text>
        <paragraph id="H4CC0B2225190400F9E3EF8D47F6067FE">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:1/sp:D">paragraph (1)(D)</cato:entity-ref>—</text>
          <subparagraph display-inline="no-display-inline" id="H0363854529FE40968F533A794661EC4C">
            <enum>(A)</enum>
            <text>by inserting <quote>
                <short-title>, designed to</short-title>
              </quote> after <quote>program</quote>; and</text>
          </subparagraph>
          <subparagraph id="H968658BAE16C49F0BA3AFE0EEFECE69F">
            <enum>(B)</enum>
            <text>by inserting <quote>, that includes the procedures described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:4">paragraph (4)</cato:entity-ref>
              </quote> after <quote>waste</quote>; and</text>
          </subparagraph>
        </paragraph>
        <paragraph id="HB66799C5D740451AB3FD3DAC29E2772A">
          <enum>(2)</enum>
          <text>by adding at the end the following:</text>
          <quoted-block display-inline="no-display-inline" id="H30EF1A0CB5F24A81B7974A5A145837E4" style="OLC">
            <paragraph id="H5557337CD8E844FAA768C0E663221030">
              <enum>(4)</enum>
              <header>Safe pharmacy access program</header>
              <subparagraph id="HCB5A9E6131BE4DB5A3F11D8EFBAD931D">
                <enum>(A)</enum>
                <header>PDP sponsor procedures</header>
                <text display-inline="yes-display-inline">A PDP sponsor (or an MA organization offering an MA–PD plan) shall have in place procedures designed—</text>
                <clause id="HCFFB7978D1364DD090F3A5686BD2B420">
                  <enum>(i)</enum>
                  <text display-inline="yes-display-inline">to identify an individual who has obtained coverage for a covered part D drug that is a frequently abused schedule II, III, IV, or V controlled substance, as determined in accordance with utilization guidelines established by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> and the sponsor (or MA organization), and to notify such individuals that they have been so identified;</text>
                </clause>
                <clause id="HD385CD4B39BE46F5AF866F189E9D38AB">
                  <enum>(ii)</enum>
                  <text>to contract with pharmacies authorized to dispense such controlled substances to create a safe pharmacy network that meets the criteria specified in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:4/sp:C" proposed="true">subparagraph (C)</cato:entity-ref>;</text>
                </clause>
                <clause id="HE4675BB709FD4D5D8752D7656D4476B3">
                  <enum>(iii)</enum>
                  <text display-inline="yes-display-inline">taking into account the location of the individual’s residence (or residences), work site, mobility, and other relevant factors, to limit coverage to schedule II, III, IV, or V controlled substances for some or all classes of covered part D drugs for an individual identified under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:4/sp:A/cl:i" proposed="true">clause (i)</cato:entity-ref> (or under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:4/sp:B" proposed="true">subparagraph (B)</cato:entity-ref>) to drugs dispensed by one or more pharmacies contracted with under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:4/sp:A/cl:ii" proposed="true">clause (ii)</cato:entity-ref>;</text>
                </clause>
                <clause commented="no" id="H064A45DB8AE54130B5B7045C1C89F6D8">
                  <enum>(iv)</enum>
                  <text>to provide to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> the name, and other information that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may require, of individuals so identified and of the fact of such individual’s disenrollment (if any) from the plan of the sponsor (or the MA–PD plan offered by the MA organization);</text>
                </clause>
                <clause id="H78EF5D22A3DB4101908045511FC5406F">
                  <enum>(v)</enum>
                  <text display-inline="yes-display-inline">to provide for an appeals process whereby an individual so identified may appeal such identification on the basis that the identification was not appropriate;</text>
                </clause>
                <clause id="HA59CDAB869294311B7D6E3A1CB322C89">
                  <enum>(vi)</enum>
                  <text>to provide for a process whereby an individual so identified may petition for the termination of such identification on the basis that the limitation on coverage is no longer necessary to prevent fraud and abuse by the individual; and</text>
                </clause>
                <clause id="HD9FC81E785BC4FC6BC8FD920EFF3F561">
                  <enum>(vii)</enum>
                  <text display-inline="yes-display-inline">to provide that coverage shall be provided for a schedule II, III, IV, or V controlled substance only if it prescribed in accordance with an electronic prescribing program under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:e">subsection (e)</cato:entity-ref>, except in such exceptional circumstances as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may permit.</text>
                </clause>
              </subparagraph>
              <subparagraph commented="no" id="HE17C79EAE13F4B609443B5514CB32441">
                <enum>(B)</enum>
                <header>Sharing information for subsequent plan enrollments</header>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall share information, with respect to the identity of an individual identified under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:4/sp:A/cl:i" proposed="true">subparagraph (A)(i)</cato:entity-ref> who disenrolls from a plan under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:4/sp:A/cl:iv" proposed="true">subparagraph (A)(iv)</cato:entity-ref>, with a PDP sponsor (or MA organization) that subsequently enrolls such individual under another plan in order that the provisions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:4/sp:A/cl:iii" proposed="true">subparagraph (A)(iii)</cato:entity-ref> would apply under such subsequent enrollment.</text>
              </subparagraph>
              <subparagraph id="H07E0FC7BD6324499883B7C6C5BF92E3E">
                <enum>(C)</enum>
                <header>Safe pharmacy network criteria</header>
                <text>The criteria specified in this subparagraph for a safe pharmacy network are the following:</text>
                <clause id="H9AA7817E92214EF49E86A71EB08EE65D">
                  <enum>(i)</enum>
                  <text display-inline="yes-display-inline">The pharmacies in the network are able to properly monitor the usage of schedule II, III, IV, and V controlled substances.</text>
                </clause>
                <clause id="H7B53E3FD255945D88070AD4B79800B04">
                  <enum>(ii)</enum>
                  <text display-inline="yes-display-inline">Such pharmacies and network meet such other drug safety criteria as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> or the PDP sponsor (or MA organization) determines to be appropriate, such as use of a State prescription drug monitoring program, if such a program is available in the State.</text>
                </clause>
              </subparagraph>
            </paragraph>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
        </paragraph>
      </subsection>
      <subsection commented="no" id="H9A7E07ED2AB046D1A48A6ECCC81D3576">
        <enum>(b)</enum>
        <header>Dual eligibles</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1860D–1/ss:b/p:3/sp:D">Section 1860D–1(b)(3)(D) of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-101">
              <cato:entity-ref entity-type="uscode" value="usc/42/1395w–101/b/3/D">42 U.S.C. 1395w–101(b)(3)(D)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by inserting <quote>, subject to such limits as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may establish for individuals identified pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:c/p:4/sp:A/cl:i" proposed="true">section 1860D–4(c)(4)(A)(i)</cato:entity-ref>
          </quote> after <quote>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref>
          </quote>.</text>
      </subsection>
      <subsection commented="no" id="HE2F78E5B943A4B64AC60C1D643C2919B">
        <enum>(c)</enum>
        <header>Effective date</header>
        <text display-inline="yes-display-inline">The amendments made by this section shall apply with respect to plan years beginning after the date that is 8 months after the date of the enactment of this Act.</text>
      </subsection>
    </section>
    <section id="H1F6FE22FF3F142649500E5F76587464D">
      <enum>3.</enum>
      <header>Part D suspension of claims payment</header>
      <text display-inline="no-display-inline">Amend <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Social Security Act/s:1860D–12/ss:c/p:4">1860D–12(b)(4) of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-112">
            <cato:entity-ref entity-type="uscode" value="usc/42/1395w–112/b/4">42 U.S.C. 1395w–112(b)(4)</cato:entity-ref>
          </external-xref>)</cato:entity> is amended by adding at the end the following new subparagraph:</text>
      <quoted-block display-inline="no-display-inline" id="H78FAADB6E5514DAAA262AD02E5F00E2D" style="OLC">
        <subparagraph id="H8FEEFD368D5B43AFB5309B2436CD1A93">
          <enum>(H)</enum>
          <header>Suspension of payments pending investigation of credible allegations of fraud by pharmacies</header>
          <clause id="HF63EF7BA02C94BEAB27F8C0718A6BFA4">
            <enum>(i)</enum>
            <header>In general</header>
            <text display-inline="yes-display-inline">A PDP sponsor may suspend payments and clean claim notifications to a pharmacy pending an investigation of a credible allegation of fraud (as defined in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–12/ss:c/p:4/sp:H/cl:ii" proposed="true">clause (ii)</cato:entity-ref>) against the pharmacy, unless the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> determines there is a good cause not to suspend payments.</text>
          </clause>
          <clause id="HC6915FB836F548FC9AE6288A944D5144">
            <enum>(ii)</enum>
            <header>Credible allegation of fraud defined</header>
            <text display-inline="yes-display-inline">In this subparagraph, the term <term>credible allegation of fraud</term> includes—</text>
            <subclause id="H6D3995EA09A0457C9E7317AE2998BDCF">
              <enum>(I)</enum>
              <text>a complaint made on the Medicare fraud hotline;</text>
            </subclause>
            <subclause id="H97081000322B472E81259C8214660B22">
              <enum>(II)</enum>
              <text>detection of potential fraud through the analysis of claims data;</text>
            </subclause>
            <subclause id="HE847B8E2222149FEA1513B5D55FFF4C1">
              <enum>(III)</enum>
              <text>detection of potential fraud through identification of inappropriate dispensing through audits, civil false claims cases, and law enforcement investigations; and</text>
            </subclause>
            <subclause id="H3796076918CD442AAD7F94EEB49E21DA">
              <enum>(IV)</enum>
              <text>claims referred to Medicare drug integrity contractors (MEDICs).</text>
            </subclause>
          </clause>
          <clause id="H5F562EB3FAEB4E84844286BBE305AEB7">
            <enum>(iii)</enum>
            <header>Rule of construction</header>
            <text>Nothing in this subparagraph shall be construed as limited the authority of a PDP sponsor to conduct post-claim payment review.</text>
          </clause>
        </subparagraph>
        <after-quoted-block>.</after-quoted-block>
      </quoted-block>
    </section>
    <section id="HB5D8B2729502477EA12FE86C39892B90">
      <enum>4.</enum>
      <header>Improving activities of Medicare Drug Integrity Contractors (MEDICs)</header>
      <subsection id="H5A091C951F3748B4BE1C87CCF02A0578">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1893">Section 1893 of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395ddd">
              <cato:entity-ref entity-type="uscode" value="usc/42/1395ddd">42 U.S.C. 1395ddd</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by adding at the end the following new subsection:</text>
        <quoted-block display-inline="no-display-inline" id="HB6C3C98A5DA246679059AB01A2FCE057" style="OLC">
          <subsection id="HB0BD59B9B8E44A7980B3E65FD70B5F2B">
            <enum>(j)</enum>
            <header>Improving activities of Medicare Drug Integrity Contractors (MEDICs)</header>
            <paragraph id="H9E5BCDD9EF084810B6E375F866F19773">
              <enum>(1)</enum>
              <header>Access to In general</header>
              <text display-inline="yes-display-inline">Under contracts entered into under this section (each in this subsection referred to as a <term>MEDIC contract</term>) with Medicare drug integrity contractors (each in this subsection referred to as a <term>MEDIC</term>), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall authorize MEDICs to directly obtain prescription and medical records from entities such as pharmacies, PDP and physicians.</text>
            </paragraph>
            <paragraph id="H505F2E5A47F2446292F345661ADAEEF2">
              <enum>(2)</enum>
              <header>Requirement for acknowledgment of referrals</header>
              <text>If a PDP sponsor refers information to a MEDIC for investigation, under the MEDIC contract the MEDIC must acknowledge receipt of the referral and must report back to the sponsor the result of the MEDIC’s investigation within 45 days of the date of the referral and share such results with appropriate agencies, such as law enforcement officials and State licensing authority.</text>
            </paragraph>
            <paragraph id="H29E2E77C4AA6406A87C32782384EB611">
              <enum>(3)</enum>
              <header>Uniform annual report criteria</header>
              <text>In order to assess the performance of MEDICs, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall develop a uniform reporting criteria for the annual reporting of the results of investigations by MEDICs to the Secretary and to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref>. Each such annual report shall include information on the number of referrals for investigation made to a MEDIC, the average time required for investigation, the results of the investigation, and the number of results that were referred to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7504">Inspector General of the Department of Health and Human Services</cato:entity-ref> and to State licensing officials for further investigations.</text>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
      <subsection id="HBA24B2FC718340E39FE797B4663CCD8F">
        <enum>(b)</enum>
        <header>Effective date</header>
        <text>The amendment made by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall take effect on the date of the enactment of this Act and shall apply as quickly as possible to MEDIC contracts, including MEDIC contracts entered into before such date of enactment.</text>
      </subsection>
    </section>
    <section id="H76262ABCFAA84AA2BF32B3311D838DAC">
      <enum>5.</enum>
      <header>Requiring e-prescribing for coverage of covered part D controlled substances</header>
      <subsection id="H8009A39A21794B7E93B12F5236252194">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Social Security Act/s:1860D–4/ss:e">Section 1860D–4(e) of the Social Security Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-104">
              <cato:entity-ref entity-type="uscode" value="usc/42/1395w–104/e">42 U.S.C. 1395w–104(e)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by adding at the end the following:</text>
        <quoted-block display-inline="no-display-inline" id="HCDC4EEAF371C4079B013A1AEF792E40D" style="OLC">
          <paragraph id="HC41F4E13C6154AE78EE6D2FEC9B93D16">
            <enum>(7)</enum>
            <header>Requirement of e-prescribing for controlled substances</header>
            <text display-inline="yes-display-inline">Except in such emergent circumstances as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> may specify, coverage shall not be provided for a covered part D drug under a prescription drug plan (or under an MA–PD plan) for a schedule II, III, IV, or V controlled substance unless the prescription for the drug has been transmitted electronically in accordance with an electronic prescription drug program that meets the requirements of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Social Security Act/s:1860D–4/ss:e/p:2">paragraph (2)</cato:entity-ref>.</text>
          </paragraph>
          <after-quoted-block>. </after-quoted-block>
        </quoted-block>
      </subsection>
      <subsection id="HF12D0503A63742DE8B74378B3CA3E343">
        <enum>(b)</enum>
        <header>Effective date</header>
        <text>The amendment made by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013/s:5/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall apply to coverage of drugs prescribed on or after January 1, 2015.</text>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>